Evidence map›Paper›PMID 37125045›Full record

ArticleFrontiers in nutrition2023

Effects of the probiotic

Giuditta Pagliai, Maria Magdalena Coman, Simone Baldi, Monica Dinu, Giulia Nannini, Edda Russo, Lavinia Curini, Barbara Colombini, Sofia Lotti, Marco Pallecchi and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Giuditta PagliaiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Maria Magdalena ComanSynbiotec S.r.l, Camerino, Italy.
Simone BaldiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Monica DinuDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Giulia NanniniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Edda RussoDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Lavinia CuriniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Barbara ColombiniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Sofia LottiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Marco PallecchiDepartment of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Leandro Di GloriaDepartment of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence, Italy.
Gianluca BartolucciDepartment of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Matteo RamazzottiDepartment of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence, Italy.
Maria Cristina VerdenelliSynbiotec S.r.l, Camerino, Italy.
Francesco SofiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Amedeo AmedeiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
University of Florence · ITAzienda Ospedaliero-Universitaria Careggi · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aim: In recent decades, obesity prevalence has reached epidemic proportions and considering the pivotal role of gut microbiota (GM) in the regulation of energy balance, alternative non-pharmacological approaches involving probiotics' administration have been proposed. The aim of the present study was to evaluate the effect of Methods: Forty overweight/obese subjects were randomly assigned to daily consume the probiotic Results: Compared to placebo, probiotic supplementation determined a significant decrease in body weight, BMI, waist circumference, waist-to-height ratio, and blood glucose. Moreover, probiotic administration produced a significant decrease of the genera Conclusion: Thanks to its effect in increasing some beneficial gut bacteria and lowering effects on waist circumference, fasting glucose levels and gastrointestinal symptoms of obese subjects,

Indexed as

clinical trialgut microbiotaLactiplantibacillus plantarum IMC 510®obesityprobiotic supplementation

Identifiers

PMID37125045
PMCPMC10130646
OpenAlexW4364360577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.